Hercules Capital Inc

Hercules Capital Inc(HTGC)股票分析

$16.660

+0.327 (+1.96%)收盘时

Loading chart…
最高
16.740
开盘
16.470
成交量加权均价
16.60
成交量
1.17M
市值
3.29B
最低
16.390
成交额
19.43M
企业价值/息税折旧摊销前利润(TTM)
10.33

Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing senior secured loans to venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value, through its investments in primarily structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, telecommunications equipment and media, semiconductor capital equipment, information technology infrastructure, and others.

AI 分析 of Hercules Capital Inc (HTGC)

持有

Hercules Capital is currently priced at $16.51, with a forward P/E ratio of 8.61, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 34.17, suggesting the stock is oversold and may continue to face downward pressure in the short term. The main risk is the recent decline in net income, which fell to $41.66 million in Q1 2026, down from $61.83 million in Q4 2025, indicating potential volatility in earnings.

分析师评级(11)

上行空间 +20.29%
买入
7 买入
4 持有
0 卖出
当前: 16.66
最低
18.00
平均
20.04
最高
24.00

UBS

2026-09-01

目标价

—

买入

Ladenburg

2026-07-31

目标价

$20

买入

UBS

2026-05-18

目标价

$15

中性

Ladenburg

2026-05-06

目标价

$21

买入

Piper Sandler

2026-05-06

目标价

$17

中性

估值指标

Hercules Capital Inc(HTGC)当前预期市盈率为 8.61,5 年平均预期市盈率为 9.16。

预期市盈率

合理
5 年均值 P/E
9.16
当前P/E
8.61
高估
10.68
低估
7.64

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
1.79
当前EV/EBITDA
10.33
高估
5.96
低估
-2.37

预期市销率

合理
5 年均值 P/S
5.42
当前P/S
4.91
高估
6.24
低估
4.60

Alphio AI 对 HTGC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%HTGC

$22.20

情景价格

基

基准

基准 · 50%HTGC

$20.63

情景价格

悲

悲观

悲观 · 25%HTGC

$20.43

情景价格

持有 HTGC 的大户

A

Ares Management LLC

+ 持有HTGC

-2.59%

3个月收益率

事件时间线

2026-10-06 (ET)

16:30:00

Rocket Pharmaceuticals Enters $150 Million Credit Facility with Hercules Capital

2026-09-29 (ET)

07:30:00

NorthStar Medical Technologies Signs Up to $185M Growth Capital Facility with Hercules Capital

2026-07-30 (ET)

16:30:00

Hercules Capital Reports Q2 NII of 50c, Beating Consensus of 48c

2026-06-03 (ET)

07:10:00

Perk Closes $300M Private Credit Facility

2026-05-15 (ET)

08:50:00

Significant Increases in Borrow Rates for Liquid Options

资讯

HTGC 常见问题 —— 由 Alphio AI 解答

Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing senior secured loans to venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value, through its investments in primarily structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, telecommunications equipment and media, semiconductor capital equipment, information technology infrastructure, and others. It operates in the Financials sector.

Hercules Capital is currently priced at $16.51, with a forward P/E ratio of 8.61, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 34.17, suggesting the stock is oversold and may continue to face downward pressure in the short term. The main risk is the recent decline in net income, which fell to $41.66 million in Q1 2026, down from $61.83 million in Q4 2025, indicating potential volatility in earnings.

11 analysts cover HTGC: 7 rate it Buy, 4 Hold and 0 Sell. The average price target is 20.04.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易